ERBB2 and non-small cell lung carcinoma: The overexpression of HER-2/neu in NSCLC has been associated with a poorer survival and shortened time to relapse (Tateishi et al, 1991; Hsieh et al, 1998; Brabender et al, 2001; Korrapati et al, 2001) but these studies were limited by small sample sizes and multivariate analysis was not performed.